These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32086979)

  • 1. MicroRNA-361-3p is a potent therapeutic target for oral squamous cell carcinoma.
    Ogawa H; Nakashiro KI; Tokuzen N; Kuribayashi N; Goda H; Uchida D
    Cancer Sci; 2020 May; 111(5):1645-1651. PubMed ID: 32086979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1.
    Chou ST; Peng HY; Mo KC; Hsu YM; Wu GH; Hsiao JR; Lin SF; Wang HD; Shiah SG
    J Exp Clin Cancer Res; 2019 Jun; 38(1):281. PubMed ID: 31253192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.
    Guo J; Wen N; Yang S; Guan X; Cang S
    Biomed Pharmacother; 2018 Aug; 104():77-86. PubMed ID: 29772443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of miR-103a-3p suppresses the proliferation in oral squamous cell carcinoma cells via targeting RCAN1.
    Zhang G; Chen Z; Zhang Y; Li T; Bao Y; Zhang S
    Neoplasma; 2020 May; 67(3):461-472. PubMed ID: 32122140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
    Tseng HH; Tseng YK; You JJ; Kang BH; Wang TH; Yang CM; Chen HC; Liou HH; Liu PF; Ger LP; Tsai KW
    Anticancer Res; 2017 Mar; 37(3):1059-1066. PubMed ID: 28314265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-223-3p inhibits proliferation and metastasis of oral squamous cell carcinoma by targeting SHOX2.
    Sun C; Liu XH; Sun YR
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6927-6934. PubMed ID: 31486492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
    He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J
    Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
    Cai J; Qiao B; Gao N; Lin N; He W
    Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2.
    Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
    Pathol Res Pract; 2019 Apr; 215(4):660-667. PubMed ID: 30606659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA-99b-3p functions as a potential tumor suppressor by targeting glycogen synthase kinase-3β in oral squamous cell carcinoma Tca-8113 cells.
    He K; Tong D; Zhang S; Cai D; Wang L; Yang Y; Gao L; Chang S; Guo B; Song T; Li A; Huang C
    Int J Oncol; 2015 Oct; 47(4):1528-36. PubMed ID: 26315788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2.
    Wang X; Li GH
    J Cell Physiol; 2018 Dec; 233(12):9447-9457. PubMed ID: 30136280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.
    Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH
    J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
    Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
    Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
    Wang K; Jin J; Ma T; Zhai H
    J Cell Mol Med; 2017 Dec; 21(12):3730-3740. PubMed ID: 28780773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. circ-PKD2 inhibits carcinogenesis via the miR-204-3p/APC2 axis in oral squamous cell carcinoma.
    Gao L; Zhao C; Li S; Dou Z; Wang Q; Liu J; Ren W; Zhi K
    Mol Carcinog; 2019 Oct; 58(10):1783-1794. PubMed ID: 31206208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intronic miR-6741-3p targets the oncogene SRSF3: Implications for oral squamous cell carcinoma pathogenesis.
    More DA; Singh N; Mishra R; Muralidharan HP; Gopinath KS; Gopal C; Kumar A
    PLoS One; 2024; 19(5):e0296565. PubMed ID: 38781195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
    Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L
    Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
    Li L; Ma HQ
    Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.